MANE - CIK 0001827635
The table below shows Veradermics, Inc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 |
|---|---|
| Cash & equivalents | $168.41M |
| Short-term investments | - |
| Receivables | - |
| Inventory | - |
| Total current assets | $397.07M |
| Property, plant & equipment | $21.00K |
| Goodwill | - |
| Total assets | $397.36M |
| Accounts payable | $1.07M |
| Total current liabilities | $6.72M |
| Long-term debt | - |
| Total liabilities | $6.72M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$150.65M |
| Total equity | $390.64M |